A monthly 10 mg/mL maintenance dose of Leqembi had the same effects on mild Alzheimer’s symptoms as biweekly dose, research ...
The drug received accelerated approval in October 2017 as monotherapy for adults with MCL who have received at least one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback